1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Cancer
  5. Metastases

Zolbetuximab with nab-paclitaxel and gemcitabine for untreated claudin 18.2-positive metastatic pancreatic cancer [ID6444]

Awaiting development [GID-TA11560] Expected publication date: TBC

  • Project information
  • Project documents

27353-Zolbetuximab-Nab-paclitaxel-Gemcitabine-for-Pancreatic-Adenocarcinoma-V1.0-APR2024-NON-CONF.pdf (nihr.ac.uk)